Semaphorins as Regulators of Chronic Mucosal Inflammatory Conditions
Semaphorins are a large family of proteins involved in the pathogenesis of inflammatory diseases through the regulation of immune homeostasis and tissue inflammation. Several members of semaphorin family proteins have been recently defined as active and non-redundant players in the inflammatory response regulatingimmune cells, smooth muscle cells, endothelial cells and eosinophils.
Related Conference of Semaphorins as Regulators of Chronic Mucosal Inflammatory Conditions
March 09-10, 2026
21th International Conference on Allergic Diseases and Clinical Immunology
Singapore City, Singapore
April 16-17, 2026
13th World Congress and Exhibition on Antibiotics and Antibiotic Resistance
London, UK
Semaphorins as Regulators of Chronic Mucosal Inflammatory Conditions Conference Speakers
Recommended Sessions
- Allergic Asthma Treatment and Prevention
- Child Vaccination & Immunization / Pediatric Vaccines
- Mucosa immunization Industries
- Mucosal Diseases
- Mucosal Immunity and Vaccines
- Mucosal Immunology in Urology
- Mucosal Immunology of HIV Infection
- Mucosal Immunology of Host Defenses
- Mucosal Immunology of Infectious Diseases
- Mucosal Immunology of Parasitic Diseases
- Mucosal Melanoma
- Mucosal Vaccination
- Mucosal Vaccines Adjuvants
- Semaphorins as Regulators of Chronic Mucosal Inflammatory Conditions
- Sinus Mucosal
- Vaccine Delivery Systems
- Vaccines Against Infectious Diseases and Cancers
- Veterinary Vaccines
Related Journals
Are you interested in
- Antibiotic Prophylaxis - Antibiotics 2026 (UK)
- Antibiotic Resistance: Opportunities and Challenges - Antibiotics 2026 (UK)
- Antibiotic-resistant Bacterial infections - Antibiotics 2026 (UK)
- Antibiotics - Antibiotics 2026 (UK)
- Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- Antibiotics: In Pregnancy and Lactation - Antibiotics 2026 (UK)
- Antimicrobial Peptides - Antibiotics 2026 (UK)
- Antimicrobial Therapy - Antibiotics 2026 (UK)
- Clinical Trials of Antibiotics - Antibiotics 2026 (UK)
- Current Research in Antibiotic Resistance - Antibiotics 2026 (UK)
- Developing Alternatives to Antibiotics - Antibiotics 2026 (UK)
- Drug Discovery and Novel Delivery Technologies - Antibiotics 2026 (UK)
- Immunology & Vaccines - Antibiotics 2026 (UK)
- Infectious Diseases - Antibiotics 2026 (UK)
- Mechanisms and Evolution of Antibiotic Resistance - Antibiotics 2026 (UK)
- Micro Organisms in Recent Drug Discovery - Antibiotics 2026 (UK)
- Microorganisms Producing Antibiotics - Antibiotics 2026 (UK)
- Modern Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- New antibiotics and non-antibiotic approaches - Antibiotics 2026 (UK)
- Pharmacokinetics and Pharmacodynamics of Antimicrobial Drugs - Antibiotics 2026 (UK)
- Pharmacology & Toxicology - Antibiotics 2026 (UK)
- Prevention and Control of Antibiotic Resistance - Antibiotics 2026 (UK)
- The Next Generation Approach of Antibiotics - Antibiotics 2026 (UK)